Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Biograil
company
About
Biograil is a biotech company manufacturing an oral device for delivery of biologics
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- €3M
- Industries
- Biotechnology,Manufacturing
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery of the biologic efficiently into the gastrointestinal wall.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€3M
Biograil has raised a total of
€3M
in funding over 2 rounds. Their latest funding was raised on
Jan 17, 2020 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 17, 2020 | Seed | €3M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Biograil is funded by 3 investors.
Verve Ventures
and Megatrend Invest
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Verve Ventures
|
— | Seed |
|
|
— | Seed |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
